MCL1 and B-cell chronic lymphocytic leukemia: In primary B cells isolated from patients with CLL, Mcl-1 protein expression has been shown to correlate with an adverse prognosis if combined with other prognostic markers, such as the stage of the disease, IgVH mutation status, ZAP-70 positivity and CD38 expression (Pepper et al, 2008).